Extremely hypo-osmolar intravenous solutions to treat hypernatremia

The time has come to stop

Erstad, Brian L PharmD, FASHP, MCCM, FCCP
Huckleberry, Yvonne C PharmD, BCPS, FCCM

Department of Pharmacy Practice and Science, University of Arizona, Tucson, AZ, USA
Banner University Medical Center, Tucson, AZ, USA

Address correspondence to Dr. Erstad ([email protected]). Twitter: @BrianErstad

Revised January 08, 2022

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

American Journal of Health-System Pharmacy 79(13):p 1122-1125, July 01, 2022. | DOI: 10.1093/ajhp/zxab480